Skip to content

Clinical trials

Observational Arthritis, Rheumatoid trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Arthritis, Rheumatoid Phase: Observational Clear all

1,035 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20017
200211
200313
200420
200514
200630
200726
200825
200942
201048
201155
201270
201339
201445
201549
201650
201745
201847
201950
202064
202157
202243
202348
202444
202541
202634

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed584
Unknown status185
Recruiting79
Terminated60
Active, not recruiting47
Not yet recruiting41
Withdrawn24
Enrolling by invitation12
Suspended3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche76
Pfizer53
Assiut University42
Bristol-Myers Squibb34
Zimmer Biomet33
AbbVie (prior sponsor, Abbott)21
AbbVie20
Assistance Publique - Hôpitaux de Paris17
MicroPort Orthopedics Inc.12
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)12

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Arthritis, Rheumatoid1,035
Arthritis, Psoriatic110
Osteoarthritis107
Spondylitis, Ankylosing88
Arthritis57
Osteonecrosis51
Crohn Disease45
Lupus Erythematosus, Systemic43
Spondylarthritis37
Psoriasis34

Trials

Showing 26 to 50 of 1,035. Each trial links to its page on Pharma Observatory.

935 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.